SPY369.85+3.16 0.86%
DIA302.59+2.53 0.84%
IXIC12,464.23+87.05 0.70%

Ovid Therapeutics Q3 EPS $(0.28) Up From $(0.43) YoY

Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.28) per share. This is a 34.88 percent increase over losses of $(0.43) per share from the same period last year.

· 11/12/2020 16:18
Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.28) per share. This is a 34.88 percent increase over losses of $(0.43) per share from the same period last year.